Glioblastoma: all 1,951 studies
Page 16 of 20. Open to participants first (457), then studies with results posted, then the rest; newest registration first within each.
- A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced CancerWithdrawnNCT02038699Phase 1/2
- Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By SurgeryTerminatedNCT02031965Phase 1
- Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in GlioblastomaCompletedNCT02029573Phase 2
- Image Guided Reirradiation of High-grade GliomaTerminatedNCT02025231Phase 1/2
- Immunophenotyping From Blood of Patients With Malignant GliomasCompletedNCT02022384
- Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma MultiformeCompletedNCT02017249Phase 1
- Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent GlioblastomaCompletedNCT02010606Phase 1
- Metabolic Tumor Volumes in Radiation Treatment of Primary Brain TumorsCompletedNCT02006563
- Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS TumorsCompletedNCT01999270Phase 1
- 3T MRI Biomarkers of Glioma Treatment ResponseTerminatedNCT01996527Early Phase 1
- An Efficacy Study Of Ortataxel In Recurrent GlioblastomaCompletedNCT01989884Phase 2
- Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain TumorCompletedNCT01985256Phase 1
- A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70Active, not recruitingNCT01985087Phase 1/2
- p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System TumorsCompletedNCT01975116Phase 1
- Dovitinib (TKI258) in the Treatment of Patients With Relapsed GlioblastomaStatus unknownNCT01972750Phase 1
- ANG1005 in Patients With Recurrent High-Grade GliomaCompletedNCT01967810Phase 2
- Phase I Study of Safety and Immunogenicity of ADU-623CompletedNCT01967758Phase 1
- Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed GlioblastomaCompletedNCT01957956Early Phase 1
- Virus DNX2401 and Temozolomide in Recurrent GlioblastomaCompletedNCT01956734Phase 1
- NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma MultiformeTerminatedNCT01954576Not applicable
- A Explore Study of Bevacizumab Combined With Conventional Therapy in GlioblastomaStatus unknownNCT01939574Not applicable
- Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma MultiformeCompletedNCT01934361Phase 1
- Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for GlioblastomaSuspendedNCT01933815Phase 1/2
- Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer SurvivorsCompletedNCT01929720Not applicable
- CT Perfusion in the Prognostication of Cerebral High Grade GliomaCompletedNCT01923922Not applicable
- Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in GlioblastomaCompletedNCT01920191Phase 1/2
- Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With TemozolomideCompletedNCT01907165Early Phase 1
- A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid NeoplasmCompletedNCT01905228Phase 1
- STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the BrainCompletedNCT01904123Phase 1
- ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma MultiformeActive, not recruitingNCT01903330Phase 2
- Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain TumorsTerminatedNCT01902771Phase 1
- Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent GlioblastomaTerminatedNCT01898273Phase 2
- Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With GlioblastomaCompletedNCT01880008
- Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma MultiformeCompletedNCT01873469
- Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept StudyCompletedNCT01872221Not applicable
- MET-PET for Newly Diagnosed GlioblastomaCompletedNCT01867593Early Phase 1
- Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma MultiformeCompletedNCT01866449Phase 2
- Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot StudyCompletedNCT01865162Phase 1
- Valproic Acid in Childhood Progressive Brain TumorsWithdrawnNCT01861990Phase 1
- A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With GlioblastomaCompletedNCT01860638Phase 2
- Peptide Vaccine for Glioblastoma Against Cytomegalovirus AntigensWithdrawnNCT01854099Phase 1
- MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT01851733Phase 1
- Evaluating the Expression Levels of MicroRNA-10b in Patients With GliomasTerminatedNCT01849952
- Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent GlioblastomaCompletedNCT01849146Phase 1
- A Phase I Study of Mebendazole for the Treatment of Pediatric GliomasActive, not recruitingNCT01837862Phase 1/2
- Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma PatientsCompletedNCT01836536Not applicable
- Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVACompletedNCT01833273Phase 1
- A Phase III Study of Re-Irradiation in Recurrent GlioblastomaWithdrawnNCT01830101Phase 3
- Response Monitoring Trial in Patients With Suspected Recurrence of GlioblastomaCompletedNCT01813877Not applicable
- A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastoma PatientsCompletedNCT01812616Phase 1/2
- Combined Cytotoxic and Immune-Stimulatory Therapy for GliomaCompletedNCT01811992Phase 1
- MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMASCompletedNCT01811121Phase 3
- Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or GlioblastomaCompletedNCT01810744Not applicable
- Dendritic Cell (DC) Vaccine for Malignant Glioma and GlioblastomaCompletedNCT01808820Phase 1
- Angiotensin II Receptor Blockers, Steroids and Radiotherapy in GlioblastomaCompletedNCT01805453Phase 3
- Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma MultiformeCompletedNCT01800695Phase 1
- Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor SurgeryStatus unknownNCT01798771Not applicable
- Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With BevacizumabWithdrawnNCT01788280Phase 2
- Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)WithdrawnNCT01782976Phase 2
- A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme PatientsCompletedNCT01770626Early Phase 1
- A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade GliomasStatus unknownNCT01765088Phase 3
- Proteome-based Personalized Immunotherapy of GlioblastomaStatus unknownNCT01759810Phase 2/3
- Post-approval Study of NovoTTF-100A in Recurrent GBM PatientsTerminatedNCT01756729Phase 4
- A Phase I Trial of High-Dose Ascorbate in Glioblastoma MultiformeCompletedNCT01752491Phase 1
- Procarbazine and Lomustine in Recurrent GlioblastomaStatus unknownNCT01737346Phase 2
- A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple MyelomaCompletedNCT01723020Phase 1
- Curcumin Bioavailability in Glioblastoma PatientsCompletedNCT01712542
- Re-irradiation of High Grade Gliomas: a Quality of Life StudyWithdrawnNCT01711580
- Derivation of Tumor Specific HybridomasTerminatedNCT01702792Phase 1
- Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT01702610Not applicable
- Phase-1 Study of Folinic Acid to Modulate MGMT Gene in GlioblastomaTerminatedNCT01700569Phase 1
- NOA-12: BIBF1120 and R-RT in GlioblastomaTerminatedNCT01666600Phase 1/2
- Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant GliomaStatus unknownNCT01656980Phase 3
- Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade GliomasCompletedNCT01653834Not applicable
- Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant GliomaStatus unknownNCT01637753Not applicable
- A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent GlioblastomaCompletedNCT01632228Phase 2
- 89Zr-RO5323441 PET Imaging in GlioblastomaWithdrawnNCT01622764Phase 2
- An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second RelapseCompletedNCT01618747
- Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma MultiformeCompletedNCT01604590
- A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)CompletedNCT01602588Phase 2
- An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)CompletedNCT01598597
- Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma MultiformeCompletedNCT01591577Phase 2
- A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme PatientsCompletedNCT01588769Phase 1
- Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)TerminatedNCT01587144Phase 2
- Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent GlioblastomaCompletedNCT01582516Phase 1/2
- Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma PatientsStatus unknownNCT01579253
- Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsCompletedNCT01576666Phase 1
- Study of DC Vaccination Against GlioblastomaStatus unknownNCT01567202Phase 2
- A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent GlioblastomaCompletedNCT01562197Phase 2
- A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade GliomaCompletedNCT01547546Phase 1
- Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain TumorsActive, not recruitingNCT01535911Not applicable
- Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First RecurrenceTerminatedNCT01526837Phase 1
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsCompletedNCT01522820Phase 1
- PET/CT Imaging of Malignant Brain Tumors With 124I-NM404CompletedNCT01516905
- Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of GlioblastomaTerminatedNCT01507506Phase 3
- Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the ElderlyCompletedNCT01502241Phase 3
- Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent GlioblastomaTerminatedNCT01499251Phase 1
- A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive GlioblastomaCompletedNCT01498328Phase 2
- Biomarkers for Prognosis of Glioblastoma (GBM)CompletedNCT01493219
- Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed GlioblastomaCompletedNCT01480479Phase 3